The Allergy Wise training courses will be undergoing essential maintenance on the 7th of August and will be closed. Please do not plan to complete your course on this day as your progress may not save. Many thanks, Anaphylaxis UK.

Sign up to our free newsletter for healthcare professionals

Help us to raise the profile of serious allergies and support those who live with life-threatening allergies by subscribing to our Healthcare Professionals Newsletter.

Our newsletters are designed to provide you with clinical allergy advice, treatments and up-to-date information on clinical research and associated trials.

Please be aware that some .org domains can be blocked. To ensure you receive our information we suggest using a personal email address, not your employee email address.

Name

 

Healthcare Professionals

Tailored advice to healthcare professionals through expert-led events and a national helpline. AllergyWise, by Anaphylaxis UK, offers a wide range of paid and free courses for the awareness and accreditation of anaphylaxis and allergic reaction responses for individuals and professionals.

Latest News for Healthcare Professionals

NICE recommends first under the tongue immunotherapy for severe birch tree pollen allergy   30th July 2025

The National Institute for Health and Care Excellence (NICE) has released its final draft guidance recommending Itulazax® (Betula verrucosa)—the first sublingual (under the tongue) tablet immunotherapy, which could help up to 27,000 people in England with moderate to severe birch
[…]

Read more
EURneffy® nasal adrenaline spray approved by MHRA: first needle-free option for anaphylaxis treatment in the UK 24th July 2025

The UK medicines regulator (MHRA) has approved EURneffy®, the country’s first needle-free adrenaline nasal spray for the emergency treatment of serious allergic reactions (anaphylaxis) in adults and children weighing 30kg or more. This new option is expected to become available
[…]

Read more
New adrenaline patch for allergic reactions moves closer to approval in America  10th July 2025

Anaphylm is a medicine being developed by Aquestive Therapeutics for the emergency treatment of serious allergic reactions, including anaphylaxis.
[…]

Read more